InvestorsHub Logo
Followers 0
Posts 94
Boards Moderated 0
Alias Born 05/10/2012

Re: Whooops post# 41793

Monday, 09/16/2013 4:32:33 PM

Monday, September 16, 2013 4:32:33 PM

Post# of 403047
Whoops,

Not an investor yet. PYMX made me somewhat shy about biotech investments. I am doing DD on the company, figuring there's no rush to get in if I decide to do so.

Brilacidin actually has the potential to replace Vancomycin for ABSSSI and MRSA. Phase 2a suggested much shorter dosing times (as little as one or two days) would lead to cure. That's huge when adding up the typical costs for hospitalization. In addition, Brilacidin showed efficacy against other gram positive infections in pre-clinical trials.

But that was just the tip of the iceberg, as far as I was concerned. Their pre-clinical candidates for fungus infections, malaria and TB, were the areas I was most interested in.

I don't know how long it'll be on the internet since most of Polymedix' site is gone, but here's a link to their investor presentation: Novel Therapeutics for Infectious Diseases and Innate Immune Disorders
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News